Department of Anaesthesia, Papworth Hospital, Cambridge, UK.
Eur J Anaesthesiol. 2009 Sep;26(9):722-9. doi: 10.1097/EJA.0b013e32832c5280.
This review examines the science and methodology of blood conservation in modern anaesthetic and surgical practice. Blood transfusion is associated with increased morbidity and mortality in all surgical patients, and the reduction or even elimination of transfusion has been and continues to be the subject of much research. Blood substitutes, despite extensive investigation, have not been proved successful in trials to date, and none have entered clinical practice. Pharmacological treatments include antifibrinolytic drugs (although aprotinin is no longer in clinical use), recombinant factor VIIa, desmopressin, erythropoietin and topical haemostatic agents, and the role of each of these is discussed. Autologous blood transfusion has recently fallen in popularity; however, cell salvage is almost ubiquitous in its use throughout Europe. Anaesthetic and surgical techniques may also be refined to improve blood conservation. Blood transfusion guidelines and protocols are strongly recommended, and repetitive audit and education are instrumental in reducing blood transfusion.
这篇综述检查了现代麻醉和外科实践中血液保护的科学和方法学。输血与所有手术患者的发病率和死亡率增加有关,减少甚至消除输血一直是并且仍然是许多研究的主题。尽管血液替代品进行了广泛的研究,但迄今为止在试验中并未证明成功,并且没有一种进入临床实践。药物治疗包括抗纤维蛋白溶解药物(尽管抑肽酶已不再临床使用)、重组因子 VIIa、去氨加压素、促红细胞生成素和局部止血剂,并且讨论了每种药物的作用。自体输血最近的受欢迎程度有所下降;然而,细胞回收在整个欧洲的使用中几乎无处不在。麻醉和外科技术也可以得到改进以改善血液保护。强烈建议制定输血指南和方案,并且重复审核和教育对于减少输血至关重要。